You are here

Home » Content

Erişkin Kronik Hemodiyaliz Hastalarında Asemptomatik EKG Değişiklikleri ve İlişkili Faktörler

ECG Alterations and Related Factors in Asymptomatic Chronic Hemodialysis Patients

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2011
DOI: 
10.5262/tndt.2011.1003.11

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
OBJECTIVE: We aimed to evaluate the ECG fi ndings in asymptomatic HD patients for CVD, and to determine related factors with these fi ndings. MATERIAL and METHODS: 545 maintenance HD patients treated at 10 different HD centers were included. The patients with angina pectoris, documented coronary artery disease, heart failure, and chronic obstructive pulmonary disease were excluded. The mean complete blood count, blood biochemical tests, and lipid profi le obtained in the last three months were recorded. Standard 12-derivation ECG with 25 mm/sec speed was performed in all patients. RESULTS: P-mitrale was found in 274 patients (50.2%), ischemic T wave alterations were found in 249 patients (45.6%), left ventricular hypertrophy was found in 90 patients (16.5%), arrhythmia was found in 88 patients (16.1%), and bundle branch block was found in 83 patients (15.3%). These abnormalities, especially ischemic T wave alterations and SVH, were determined more frequently in diabetic patients and patients with lower hemoglobin level. We did not observe any differential diagnostic attempts for these alterations in last three months. CONCLUSION: ECG abnormalities are prevalent in asymptomatic HD patients. Surprisingly, whether these abnormalities result from cardiovascular disease or not has not been investigated by medical teams. We concluded that this behavior may due to the symptom-free condition, or perception of HD treatment as a routine treatment method.
Bookmark/Search this post with
Abstract (Original Language): 
AMAÇ: Düzenli HD hizmeti veren kurumlarda, kardiyovasküler hastalık açıdan asemptomatik HD hastalarında EKG bulgularını değerlendirmek ve ilişkili faktörleri belirlemek. GEREÇ ve YÖNTEMLER: Çalışmaya 10 ayrı HD merkezinde tedavi gören 545 HD hastası alındı. Angina pektoris, belgelenmiş koroner arter hastalığı ve kalp yetmezliği olan hastalar çalışma dışı bırakıldı. Hastaların son 3 ay içinde çalışılmış olan; tam kan sayımı, kan biyokimyasal testleri, lipid profi li sonuçlarının ortalamaları hesaplandı ve istatistiksel değerlendirmede kullanıldı. Tüm hastalarda, 12 derivasyonlu 25 mm/sn hızla standart elektrokardiyogram elde edildi. BULGULAR: Hastaların 274’ünde (%50,2) P-mitrale, 249’ünde (%45,6) klasik iskemik T-dalgaları, 90’ında (%16,5) sol ventrikül hipertrofi si (SVH) voltaj ölçütü, 88’inde (%16,1) ritm bozukluğu, 83’ünde (%15,2) dal bloğu belirlendi. Bu anormalliklerden özellikle iskemik T-dalga değişiklikleri (p<0,05) ve SVH’nin (p<0,01) hemoglobin düzeyi düşük hastalarda daha sık olduğu saptandı. Hastaların saptanan bu anormallikleri nedeniyle, son 3 ayda, özel bir girişimde bulunulmadığı gözlendi. SONUÇ: Asemptomatik HD hastalarında EKG anormalliği yaygındır. Bu anormallikler, sorumlu hekimleri tarama ya da tanısal testlere yöneltmemiş, üzerinde yeterince durulmamıştır. Bu durumun, hastaların asemptomatik olmasından ya da HD tedavisinin her hastaya aynı uygulanan düzenli bir tedavi yaklaşımı şeklinde algılanmasından kaynaklandığı düşünülmüştür.
FULL TEXT (PDF): 
PDF icon arastrmx_172977_20_pp_272-276.pdf
  • 3
272-276
  • Turkish

REFERENCES

References: 

1. Sniderman AD, Solhpour A, Alam A, Williams K, Sloand JA:
Cardiovascular death in dialysis patients: Lessons we can learn
from AURORA. Clin J Am Soc Nephrol 2010; 5(2): 335-340
2. Remppis A, Ritz E: Cardiac problems in the dialysis patient: Beyond
coronary disease. Semin Dial 2008; 21(4): 319-325
3. K/DOQI Workgroup: K/DOQI clinical practice guidelines for
cardiovascular disease in dialysis patients. Am J Kidney Dis 2005;
45(Suppl 3): 1-153
4. Krane V, Heinrich F, Meesmann M, Olschewski M, Lilienthal J,
Angermann C, Störk S, Bauersachs J, Wanner C, Frantz S, German
Diabetes and Dialysis Study Investigators: Electrocardiography
and outcome in patients with diabetes mellitus on maintenance
hemodialysis. Clin J Am Soc Nephrol 2009; 4(2): 394-400
5. Katerinis I, Nguyen QV, Magnin JL, Descombes E: Cardiac fi ndings
in asymptomatic chronic hemodialysis patients with persistently
elevated cardiac troponin I levels. Ren Fail 2008; 30(4): 357-362
6. Foley RN, Curtis BM, Randell EW, Parfrey PS: Left ventricular
hypertrophy in new hemodialysis patients without symptomatic
cardiac disease. Clin J Am Soc Nephrol 2010; 5(5): 805-813
7. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R,
Zampi I, Porcellati C: Prognostic value of a new electrocardiographic
method for diagnosis of left ventricular hypertrophy. J Am Coll
Cardiol 1998; 31: 383-390
8. Costa Fde A, Rivera IR, Vasconcelos ML, Costa AF, Póvoa RM,
Bombig MT, Luna Filho B, Lima VC: Electrocardiography in the
diagnosis of ventricular hypertrophy in patients with chronic renal
disease. Arq Bras Cardiol 2009; 93(4): 380-386
9. Manske CL, Thomas W, Wang Y, Wilson RF: Screening diabetic
transplant candidates for coronary artery disease: Identifi cation of a
low risk subgroup. Kidney Int 1993; 44: 617-621
10. Logar CM, Herzog CA, Beddhu S: Diagnosis and therapy of
coronary artery disease in renal failure, end stage renal disease,
renal transplant populations. Am J Med Sci 2003; 325: 214-227
11. Murphy SW, Foley RN, Parfrey PS: Screening and tratment for
cardiovascular disease in patients with chronic renal disease. Am J
Kidney Dis 1998; 32 (suppl 3): 184-199
12. Murphy SW: Management of heart failure and coronory artery
disease in patients with chronic kidney disease. Semin Dial 2003;
16: 165-172
13. Brenner&Rector’s: Cardiovascular aspects of chronic kidney
disease. The Kidney 8 th 2006; 1697-1721
14. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R,
Zampi I, Porcelatti C: Prognostic signifi cance of serial changes in
left ventricular mass in essential hypertension. Circulation 1998;
97: 48-54
15. Devereux RB: Is the electrocardiogram still useful for detection of
left ventricular hypertrophy? Circulation 1990; 81: 1144-1146
16. Levy D, Salomon M, D’Agostino RB, Belanger AJ, Kannel WB:
Prognostic implications of baseline electrocardiographic features
and their serial changes in subjects with left ventricular hypertrophy.
Circulation 1994; 90: 1786- 1793
17. Costa Fde A, Rivera IR, Vasconcelos ML, Costa AF, Póvoa RM,
Bombig MT, Luna Filho B, Lima VC: Electrocardiography in the
diagnosis of ventricular hypertrophy in patients with chronic renal
disease. Arq Bras Cardiol 2009;93(4): 380-386, 373-379
18. de Vries SO, Heesen WF, Beltman FW, Kroese AH, May JF,
Smit AJ, Lie KI: Prediction of the left ventricular mass from the
electrocardiogram in systemic hypertension. Am J Cardiol 1996;
77: 974-978
19. Korantzopoulos PG, Goudevenos JA: Atrial fi brillation in endstage
renal disease: An emerging problem. Kidney Int 2009;
76(3): 247-249
20. Vázquez E, Sánchez-Perales C, Borrego F, Garcia-Cortés MJ,
Lozano C, Guzmán M, Gil JM, Borrego MJ, Pérez V: Infl uence
of atrial fi brillation on the morbido-mortality of patients on
hemodialysis. Am Heart J 2000; 140: 886-890
21. Bozbas H, Atar I, Yildirir A, Ozgul A, Uyar M, Ozdemir N,
Muderrisoglu H, Ozin B: Prevalence and predictors of arrhythmia
in end stage renal disease patients on hemodialysis. Ren Fail 2007;
29(3): 331-339
22. Kasper D, Braunwald E, Fauci A, Hauser S, Longo D, Jameson L:
Disorders of cardiovascular system. Priciples of Internal Medicine.
(16th ed) 2005; 1312-1315
23. Tezcan UK, Amasyali B, Can I, Aytemir K, Köse S, Yavuz I,
Kursaklioglu H, Işik E, Demirtaş E, Oto A: Increased P wave
dispersion and maximum Pwave duration after hemodialysis. ANN
Noninvasive Electrocardiol 2004; 9: 34-38
24. Koçinaj D, Gashi M, Berisha M, Koçinaj A, Ramadani N, Korça
H: Echocardiographic assessment of left atrial size in patients with
end-stage renal disease. Cardiovasc J Afr 2009; 20(3): 183-186
25. Miller WL, Ballman KV, Hodge DO, Rodeheffer RJ, Hammill SC:
Risk factor implications of incidentally discovered uncomplicated
bundle branch block. Mayo Clin Proc 2005; 80(12): 1585-1590

Thank you for copying data from http://www.arastirmax.com